Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ZILA -- Ignore unavailable to you. Want to Upgrade?

To: PHILLIP FLOTOW who wrote (770)	11/9/1998 8:48:00 PM
From: Dennis Walters	Read Replies (1) \| Respond to of 897

FDA approval by March or EARLIER. Joe Hines sent a commentary and Q&A to brokers today about the FDA priority review. Someone posted it on the Yahoo "club" board (can be found in clubs at Zilaslongstockholders). Joe Garagiola, oral cancer survivor groups, and others will be working with Zila. Approval is now virtually a certainty. It will be March at the LATEST, but could be earlier, IMO. A public hearing would bring OraTest even more attention. This will provide a new floor for the stock for several months. D.W.